Research Article
Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target
Table 3
Prognostic factors in the univariate and multivariate analyses for GC patients.
| | Parameters | Univariate | Multivariate | | -value | HR | 95% CI | -value |
| | Age | 0.575 | — | — | — | | Gender | 0.792 | — | — | — | | Location | | 1.260 | 0.841–1.889 | 0.262 | | Lauren type | | 1.289 | 0.941–1.766 | 0.114 | | Borrmann type (I/II vs. III/IV) | | 1.343 | 0.847–2.130 | 0.209 | | Differentiated degree (well/moderate vs. moderate-poor/poor) | 0.906 | — | — | — | | T stage (T1+2 vs. T3+4) | 0.116 | — | — | — | | N stage (N0+1 vs. N2+3) | | 3.371 | 1.517–7.488 | | | M stage (M0 vs. M+) | | 2.744 | 1.403–5.369 | | | TNM stage (I/II vs. III/IV) | 0.142 | — | — | — | | HER2 | | — | — | — | | PD-L1 | | — | — | — | | CEA | | 1.913 | 1.166–3.138 | | | CA125 | | 2.189 | 1.085–4.415 | | | CA72-4 | 0.946 | — | — | — | | AFP | 0.568 | — | — | — | | CA19-9 | 0.112 | — | — | — | | TFR1 expression | 0.018 | 1.726 | 1.007–2.958 | |
|
|
